VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SLDB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SLDBSolid Biosciences Inc.
$9.47$738M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSLDBQuarterly Financials

Solid Biosciences Inc. (SLDB) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Solid Biosciences Inc. (SLDB) quarterly income statement — complete revenue, gross profit & net income history

SLDB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue0000000000000006.17M1.93M3.15M3.54M3.59M
Revenue Growth %------------100%-100%-100%-100%71.65%-42.28%---
Cost of Goods Sold395K00386K407K000327K00000000000
COGS % of Revenue--------------------
Gross Profit-395K00-386K-407K000-327K0000006.17M1.93M3.15M3.54M3.59M
Gross Margin %---------------100%100%100%100%100%
Gross Profit Growth %2.95%----24.46%-------100%-100%-100%-100%71.65%-42.28%---
Operating Expenses56.91M49.4M48.06M41.31M39.65M39.9M35.18M27.79M26.54M22.27M23.11M26.84M32.03M34.57M21.13M31.55M27.3M21.81M21.57M22.28M
OpEx % of Revenue---------------511.44%1418.03%691.38%609.78%619.89%
Selling, General & Admin11.17M11.27M9.2M9.28M9.14M9.13M7.86M8.33M7.99M6.81M6.41M7.13M7.4M7.62M7.13M6.85M7.35M7.21M7.14M6.77M
SG&A % of Revenue---------------111.06%381.92%228.63%201.95%188.26%
Research & Development46.14M38.13M38.86M32.41M30.91M30.77M27.33M19.46M18.87M15.45M16.7M19.78M24.63M21.29M14.01M23.18M19.95M14.6M14.43M15.51M
R&D % of Revenue---------------375.75%1036.1%462.75%407.83%431.64%
Other Operating Expenses-395K00-386K-407K000-327K00-63K01000K01000K0000
Operating Income-57.31M-49.4M-48.06M-41.69M-40.05M-39.9M-35.18M-27.79M-26.86M-22.27M-23.11M-26.84M-32.03M-34.57M-21.13M-25.38M-25.37M-18.65M-18.03M-18.68M
Operating Margin %----------------411.44%-1318.03%-591.38%-509.78%-519.89%
Operating Income Growth %-43.08%-23.83%-36.6%-50.04%-49.1%-79.19%-52.21%-3.52%16.13%35.59%-9.38%-5.76%-26.24%-85.32%-17.2%-35.84%-50.25%12.62%15.05%1.52%
EBITDA-56.91M-48.94M-47.68M-41.31M-39.65M-39.41M-34.78M-26.55M-26.54M-22.05M-22.53M-26.14M-30.95M-34.03M-20.69M-24.66M-24.66M-17.89M-17.28M-17.97M
EBITDA Margin %----------------399.74%-1281.19%-567.28%-488.52%-499.92%
EBITDA Growth %-43.56%-24.18%-37.11%-55.56%-49.41%-78.7%-54.39%-1.58%14.27%35.19%-8.85%-6%-25.5%-90.18%-19.76%-37.25%-52.69%12.94%15.55%-1.85%
D&A (Non-Cash Add-back)395K467K376K386K407K488K405K1.24M327K213K588K703K1.08M539K438K722K709K760K752K718K
EBIT-57.31M-49.4M-45.78M-39.42M-39.21M-42.52M-32.64M-24.98M-24.21M-22.27M-20.87M-24.52M-29.95M-28.91M-21.13M-23.86M-25.37M-18.65M-18.03M-18.68M
Net Interest Income2.06M2.05M2.59M2.91M2.23M1.85M2.25M2.48M2.56M1.66M1.86M1.95M1.68M0735K293K54K00-13K
Interest Income2.06M2.05M2.59M2.97M2.3M1.93M2.33M2.56M2.65M1.66M1.96M2.06M1.8M0735K293K54K000
Interest Expense00060K68K75K82K88K95K0106K111K121K00000013K
Other Income/Expense571K-384K2.28M2.21M770K-2.7M2.46M2.72M2.56M1.93M2.13M2.21M1.96M19.41M722K290K44K42K48K-10K
Pretax Income-56.74M-49.79M-45.78M-39.48M-39.28M-42.6M-32.73M-25.07M-24.3M-20.34M-20.98M-24.63M-30.07M-15.15M-20.41M-25.09M-25.33M-18.61M-17.98M-18.7M
Pretax Margin %----------------406.74%-1315.74%-590.04%-508.43%-520.17%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-56.74M-49.79M-45.78M-39.48M-39.28M-42.6M-32.73M-25.07M-24.3M-20.34M-20.98M-24.63M-30.07M-15.15M-20.41M-25.09M-25.33M-18.61M-17.98M-18.7M
Net Margin %----------------406.74%-1315.74%-590.04%-508.43%-520.17%
Net Income Growth %-44.44%-16.88%-39.88%-57.47%-61.63%-109.47%-55.98%-1.8%19.18%-34.22%-2.79%1.85%-18.72%18.59%-13.5%-34.22%-49.87%12.89%15.36%1.54%
Net Income (Continuing)-56.74M-49.79M-45.78M-39.48M-39.28M-42.6M-32.73M-25.07M-24.3M-20.34M-20.98M-24.63M-30.07M-15.15M-20.41M-25.09M-25.33M-18.61M-17.98M-18.7M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.52-0.53-0.48-0.42-0.59-0.80-0.79-0.61-0.64-0.70-1.05-1.25-1.54-1.89-2.71-3.30-3.37-2.49-2.40-2.50
EPS Growth %11.86%33.75%39.24%31.15%7.81%-14.29%24.76%51.2%58.44%62.96%61.25%62.12%54.3%24.1%-12.92%-32%-18.25%45.15%63.64%57.27%
EPS (Basic)-0.52-0.53-0.48-0.42-0.59-0.80-0.79-0.61-0.64-0.70-1.05-1.25-1.54-1.89-2.71-3.30-3.37-2.53-2.40-2.55
Diluted Shares Outstanding109.81M94.73M94.42M94.14M66.34M53.58M41.44M40.93M38.16M29.02M20.06M19.66M19.57M8.02M7.53M7.52M7.51M7.49M7.48M7.49M
Basic Shares Outstanding109.81M94.73M94.42M94.14M66.34M53.58M41.44M40.93M38.16M29.02M20.06M19.66M19.57M8.02M7.53M7.52M7.51M7.36M7.48M7.33M
Dividend Payout Ratio--------------------